Risk of colorectal cancer in patients with positive results of fecal immunochemical test performed within 5 years since the last colonoscopy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Annual fecal immunochemical tests (FITs) are often repeated within the recommended colonoscopy surveillance intervals. However, it remains unclear whether interval FITs are useful. To answer this question, we assessed the risk of colorectal cancer (CRC) according to the interval from the last colonoscopy to an FIT. Methods: Using the Korean National Cancer Screening Program database, we collected data on patients who underwent FITs in 2011. Patients with positive FIT results were classified into three groups according to their previous colonoscopy interval: 0.5 to 5 years (group 1), 5 to 10 years (group 2), and ≥ 10 years or no colonoscopy (group 3). CRC incidence was defined as CRC diagnosed within 1 year after an FIT. Results: Among 177,660 patients with positive FIT results, the incidence of CRC in groups 1, 2, and 3 was 0.72% (n = 214/29,575), 1.28% (n = 116/9,083), and 3.88% (n = 5,387/139,002), respectively. The age- and sex-adjusted risk for CRC was higher in groups 2 (odds ratio [OR], 1.79; 95% confidence interval [CI], 1.43 to 2.25) and 3 (OR, 5.56; 95% CI, 4.85 to 6.38) than in group 1. Among patients who did and did not undergo a polypectomy during the previous colonoscopy, those in group 2 had a higher rate of CRC than those in group 1 (without polypectomy: 1.15% vs. 0.63%; OR, 1.79; 95% CI, 1.37 to 2.34) (with polypectomy: 2.37% vs. 0.93 %; OR, 2.30; 95% CI, 1.44 to 3.69). Conclusion: In patients with positive FIT results who had undergone a colonoscopy within the past 5 years, the risk of CRC is very low, regardless of whether a polypectomy was performed, suggesting that interval FITs are not useful.
Abstract
Background/Aims: Annual fecal immunochemical tests (FITs) are often repeated within the recommended colonoscopy surveillance intervals. However, it remains unclear whether interval FITs are useful. To answer this question, we assessed the risk of colorectal cancer (CRC) according to the interval from the last colonoscopy to an FIT. Methods: Using the Korean National Cancer Screening Program database, we collected data on patients who underwent FITs in 2011. Patients with positive FIT results were classified into three groups according to their previous colonoscopy interval: 0.5 to 5 years (group 1), 5 to 10 years (group 2), and ≥ 10 years or no colonoscopy (group 3). CRC incidence was defined as CRC diagnosed within 1 year after an FIT. Results: Among 177,660 patients with positive FIT results, the incidence of CRC in groups 1, 2, and 3 was 0.72% (n = 214/29,575), 1.28% (n = 116/9,083), and 3.88% (n = 5,387/139,002), respectively. The age- and sex-adjusted risk for CRC was higher in groups 2 (odds ratio [OR], 1.79; 95% confidence interval [CI], 1.43 to 2.25) and 3 (OR, 5.56; 95% CI, 4.85 to 6.38) than in group 1. Among patients who did and did not undergo a polypectomy during the previous colonoscopy, those in group 2 had a higher rate of CRC than those in group 1 (without polypectomy: 1.15% vs. 0.63%; OR, 1.79; 95% CI, 1.37 to 2.34) (with polypectomy: 2.37% vs. 0.93 %; OR, 2.30; 95% CI, 1.44 to 3.69). Conclusion: In patients with positive FIT results who had undergone a colonoscopy within the past 5 years, the risk of CRC is very low, regardless of whether a polypectomy was performed, suggesting that interval FITs are not useful.
참고문헌 (18)
- Kronborg O, "Randomised study of screening for colorectal cancer with faecal-occult-blood test", Lancet, 348, pp.1467~1471 (1996)
- Hardcastle JD, "Randomised controlled trial of faecal-occult-blood screening for colorectal cancer", Lancet, 348, pp.1472~1477 (1996)
- Robertson DJ, "Recommendations on fecal immunochemical testing to screen for colorectal neoplasia : a consensus statement by the US multi-society task force on colorectal cancer", Gastroenterology, 152, pp.1217~1237 (2017)
- Rex DK, "Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer", Am J Gastroenterol, 112, pp.1016~1030 (2017)
- Macrae FA, "Optimal dietary conditions for hemoccult testing", Gastroenterology, 82, pp.899~903 (1982)
- Barrows GH, "Immunochemical detection of human blood in feces", Am J Clin Pathol, 69, pp.342~346 (1978)
- Songster CL, "Immunochemical detection of fecal occult blood : the fecal smear punchdisc test : a new non-invasive screening test for colorectal cancer", Cancer, 45, pp.1099~1102 (1980)
- Tinmouth J, "Faecal immunochemical tests versus guaiac faecal occult blood tests : what clinicians and colorectal cancer screening programme organisers need to know", Gut, 64, pp.1327~1337 (2015)
- Park DI, "Comparison of guaiacbased and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening", Am J Gastroenterol, 105, pp.2017~2025 (2010)
- Lieberman D, "Standardized colonoscopy reporting and data system : report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable", Gastrointest Endosc, 65, pp.757~766 (2007)
- Nadel MR, "Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations", J Gen Intern Med, 25, pp.833~839 (2010)
- Winawer SJ, "Guidelines for colonoscopy surveillance after polypectomy : a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society", Gastroenterology, 130, pp.1872~1885 (2006)
- Hassan C, "Post-polypectomy colonoscopy surveillance : European Society of Gastrointestinal Endoscopy(ESGE)guideline : update 2020", Endoscopy, 52, pp.687~700 (2020)
- Kawamura T, "Risk of colorectal cancer for fecal immunochemistry test-positive, average-risk patients after a colonoscopy", J Gastroenterol Hepatol, 34, pp.532~536 (2019)
- Kim NH, "Yield of repeat colonoscopy in asymptomatic individuals with a positive fecal immunochemical test and recent colonoscopy", Gastrointest Endosc, 89, pp.1037~1043 (2019)
- Liu J, "Annual fecal occult blood testing can be safely suspended for up to 5 years after a negative colonoscopy in asymptomatic average-risk patients", Am J Gastroenterol, 110, pp.1355~1358 (2015)
- Rutter MD, "British Society of Gastroenterology", Association of Coloproctology of Great Britain and Ireland, Gut, pp.2020, 69[DOI]
- Martin CS Wong, "Prevalence and risk factors of colorectal cancer in Asia", Intestinal research, 17(3), pp.317~329 (2019), 대한장연구학회[DOI]